Cognitive function in breast cancer and lymphoma patients receiving chemotherapy: An ongoing nationwide University of Rochester Cancer Center (URCC) Community Clinical Oncology Program (CCOP) observational study with 1,200 patients and controls.
Michelle C. Janelsins(University of Rochester), Gary R. Morrow(University of Rochester Medical Center), Howard M. Gross(Dayton Clinical Oncology Program), Mary Ontko(Dayton Clinical Oncology Program), Song Yao(Roswell Park Comprehensive Cancer Center), Paul Smiskol(Metro-Minnesota Community Oncology Research Consortium), Christine B. Ambrosone(Unknown), Karen M. Mustian(University of Rochester Medical Center), Charles E. Heckler(University of Rochester Medicine), Shaker R. Dakhil(Cancer Center of Kansas), Oxana Palesh(Virginia Commonwealth University), Marianne Melnik(Michigan Cancer Research Consortium), Tim A. Ahles(Memorial Sloan Kettering Cancer Center)
Cited by 0
Related Papers
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
|Proceedings of the National Academy of Sciences|2005|2.4k
Cancer-Related Fatigue, Version 2.2015
|Journal of the National Comprehensive Cancer Network|2015|951
Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue
|JAMA Oncology|2017|913
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
Metabolic gene polymorphism frequencies in control populations.
|PubMed|2001|847